Breathe Well Live Well
|
Relvar Ellipta Approved in Japan for Treatment of Asthma
Benzinga GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma (in cases where … GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … Double asthma approval in Japan lifts SkyePharma Asthma drugs head Japan approvals |
View full post on asthma – Google News
|
GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma …
RTT News GlaxoSmithKline plc(GSK: Quote,GSK.L), and Theravance, Inc.(THRX: Quote), Friday said that Relvar Ellipta for the treatment of bronchial asthma got approval from the Japanese Ministry of Health, Labour and Welfare. The company said Relvar Ellipta is … Japan approves lung drugs from GSK/Theravance and SkyePharma Glaxo's Relvar Lung Treatment Recommended by EU Regulator GlaxoSmithKline Treatments Given Positive Opinion In Europe, Approved in Japan |
View full post on asthma – Google News